Silvergate Pharma’s XATMEP pediatric drug receives FDA approval

Silvergate Pharma’s XATMEP pediatric drug receives FDA approval

DENVER -- Silvergate Pharmaceuticals, Inc. , leaders in development and commercialization of innovative and safe medicines for children, announced that the U.S. Food and Drug Administration... Read More

Thursday April 27, 2017 0 comments Tags: Denver, Silvergate Pharmaceuticals, XATMEP, Frank Segrave

CBSA honors nine leaders at annual awards dinner

CBSA honors nine leaders at annual awards dinner

DENVER -- Colorado BioScience Association (CBSA) honored nine of the states top bioscience leaders during its annual awards dinner Nov. 3. The event, held at the Omni Interlocken Resort in... Read More

Monday November 7, 2016 0 comments Tags: Denver, CBSA, CBSA Annual Awards Dinner, April Giles, Silvergate Pharmaceuticals, BiO2 Medical, Steve VanNurden, Nicole McWright, Rhea May, Denver Metro Chamber, AstraZeneca, Sen. Michael Bennet, Boettcher Foundation

Silvergate Pharmaceuticals receives FDA approval for Qbrelis to treat children

Silvergate Pharmaceuticals receives FDA approval for Qbrelis to treat children

DENVER -- Silvergate Pharmaceuticals, a leader in the development and commercialization of innovative and safe medicines for children, today announced the U.S. FDA approved Qbrelis (Lisinopril)... Read More

Monday August 1, 2016 0 comments Tags: Silvergate Pharmaceuticals, Qbrelis, Frank Segrave, Denver